References
- Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008;26: 535–61.
- Peltomaa R, Paimela L, Kautiainen H, et al. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis. 2002;61:889�94.
- Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007;46:350�7.
- Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum. 2005;52:2616�24.
- Uhfig T, Heiberg T, Mowinckel P, et al. Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis. 2008;67: 1710–5.
- Sokka T, Kautiainen H, Hakkinen A, et al. Radiographic pro-gression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol. 2004;31: 1073–82.
- Verstappen SM, Jacobs JW, Bijlsma JW, et al. Five-year fol-lowup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment accord-ing to the pyramid approach in the first year. Arthritis Rheum. 2003;48:1797–807.
- van Riel PL, Taggart AJ, Sany J, et al. Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study. Ann Rheum Dis. 2006;65: 1478–83.
- Emery P, Keystone E, Tony HP, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised pla-cebo-controlled trial. Ann Rheum Dis. 2008;67:1516–23.
- Nakajima A, Kamitsuji S, Saito A, et al. Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan. Mod Rheumatol. 2006;16:151–7.
- Yamanaka H, Inoue E, Singh G, et al. Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheu-matol. 2007;17:283–9.
- Yamada T, Nakajima A, Inoue E, et al. Increased risk of tuber-culosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis. 2006;65:1661–3.
- Tanaka E, Singh G, Saito A, et al. Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan. Mod Rheumatol. 2005;15:340–5.
- Furuya T, Kotake S, Inoue E, et al. Risk factors associated with incident fractures in Japanese men with rheumatoid arthritis: a prospective observational cohort study. J Bone Miner Metab. 2008;26:499–505.
- Momohara S, Ikari K, Mochizuki T, et al. Declining use of synovectomy surgery for patients with rheumatoid arthritis in Japan. Ann Rheum Dis. 2009;68:291–2.
- Nakajima A, Inoue E, Tanaka E, et al. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol. 2010;39: 360–7.
- Matsuda Y, Singh G, Yamanaka H, et al. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3, 763 patients with rheumatoid arthritis. Arthritis Rheum. 2003;49: 784–8.
- Wells GA, Tugwell P, Kraag GR, et al. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol. 1993;20:557–60.
- Young A, Dixey J, Cox N, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000;39:603–11.